Paper36722641
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary.
Brundu S and 15 others. EMBO Mol Med, 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary. Papers, record 36722641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36722641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms, Unknown Primary | Major topic |
| Nerve Tissue Proteins | Major topic |
| Neoplastic Stem Cells | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Axon Guidance | |
| ErbB Receptors | |
| Mutation | |
| Neoplasm Recurrence, Local |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25260700 | HTSeq--a Python framework to work with high-throughput sequencing data. | Bioinformatics | 2015 | https://conductscience.org/library/papers/25260700 | PubMed |
| 2 | 28781987 | Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape. | Oncoscience | 2017 | https://conductscience.org/library/papers/28781987 | PubMed |
| 3 | 11987783 | HIV-based vectors. Preparation and use. | Methods Mol Med | 2002 | https://conductscience.org/library/papers/11987783 | PubMed |
| 4 | 27322425 | Molecular driver alterations and their clinical relevance in cancer of unknown primary site. | Oncotarget | 2016 | https://conductscience.org/library/papers/27322425 | PubMed |
| 5 | 16584533 | The semaphorins. | Genome Biol | 2006 | https://conductscience.org/library/papers/16584533 | PubMed |
| 6 | 29124875 | Emerging functions of the EGFR in cancer. | Mol Oncol | 2018 | https://conductscience.org/library/papers/29124875 | PubMed |
| 7 | 36722641 | Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/36722641 | PubMed |
| 8 | 31363226 | Promoting transparency and reproducibility in enhanced molecular simulations. | Nat Methods | 2019 | https://conductscience.org/library/papers/31363226 | PubMed |
| 9 | 27819658 | CHARMM36m: an improved force field for folded and intrinsically disordered proteins. | Nat Methods | 2017 | https://conductscience.org/library/papers/27819658 | PubMed |
| 10 | 33514835 | Plexin-B2 facilitates glioblastoma infiltration by modulating cell biomechanics. | Commun Biol | 2021 | https://conductscience.org/library/papers/33514835 | PubMed |
| 11 | 19567251 | ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. | J Immunol Methods | 2009 | https://conductscience.org/library/papers/19567251 | PubMed |
| 12 | 26212640 | Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity. | Sci Rep | 2015 | https://conductscience.org/library/papers/26212640 | PubMed |
| 13 | 21500218 | MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. | J Comput Chem | 2011 | https://conductscience.org/library/papers/21500218 | PubMed |
| 14 | 20428780 | Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence. | Int J Oncol | 2010 | https://conductscience.org/library/papers/20428780 | PubMed |
| 15 | 32025034 | The guidance receptor plexin D1 is a mechanosensor in endothelial cells. | Nature | 2020 | https://conductscience.org/library/papers/32025034 | PubMed |
| 16 | 36346458 | Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs). | Virchows Arch | 2023 | https://conductscience.org/library/papers/36346458 | PubMed |
| 17 | 28915622 | Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway. | Oncotarget | 2017 | https://conductscience.org/library/papers/28915622 | PubMed |
| 18 | 15572123 | The versatile roles of "axon guidance" cues in tissue morphogenesis. | Dev Cell | 2004 | https://conductscience.org/library/papers/15572123 | PubMed |
| 19 | 24213581 | Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression. | Oncogene | 2014 | https://conductscience.org/library/papers/24213581 | PubMed |
| 20 | 26182302 | Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies. | JAMA Oncol | 2015 | https://conductscience.org/library/papers/26182302 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908720 | PLXNB2 promotes breast cancer progression and lung metastasis through the AMPK signaling pathway. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42908720 | PubMed |
| 42005444 | Context-Dependent Dual Roles of the Plexin-B Family in Cancer Progression: Mechanisms and Therapeutic Implications. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42005444 | PubMed |
| 39389953 | Multi-stage mechanisms of tumor metastasis and therapeutic strategies. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39389953 | PubMed |
| 37632633 | Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/37632633 | PubMed |
| 37627074 | Plexins as Regulators of Cancer Cell Proliferation, Migration, and Invasivity. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37627074 | PubMed |
| 36982662 | From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982662 | PubMed |
| 36722641 | Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/36722641 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE167473 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36722641
GET https://conductscience.org/api/papers/v1/36722641/references?page=2